21185 ⎘
Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies Veterinary vaccine
Coronavirus proteins and antigens
#902Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors
#903Live attenuated catfish vaccine and method of making
#904Method for porcine circovirus production and PCV2 vaccines
#905EXTENDED-RANGE SPRAY APPLICATOR
#906Single vial vaccine formulations
#907Traditional chinese medicine mulberry leaves polysaccharide and eucommia polysaccharide immunostimulant and application thereof
#908Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof
#909PRRS virus variant, European PRRS virus cDNA clone, and uses thereof
#910USE OF BACTERIAL ENDOTOXINS AND LIPOTEICHOIC ACIDS TO IMPROVE POSTPARTAL HEALTH AND PRODUCTIVITY OF DAIRY COWS AND THEIR NEWBORNS
#911Diagnostic test for CSFV antibodies
#912COMPOSITION
#913Compositions and methods for vaccination against influenza A virus
#914Vaccine against Lawsonia intracellularis and porcine circovirus 2
#915Fish vaccine
#916Fish vaccine
#917Composition for oral delivery of bioactive agents
#918PRRSV compositions
#919Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
#920THERAPIES, VACCINES, AND PREDICTIVE METHODS FOR BEE COLONY COLLAPSE SYNDROME
#921Gene-deleted variant strain of porcine pseudorabies virus, vaccine composition, method of making the same and use thereof
#922ATTENUATED NEGATIVE STRAND VIRUSES WITH ALTERED INTERFERON ANTAGONIST ACTIVITY FOR USE AS VACCINES AND PHARMACEUTICALS
#923proteins, nucleic acids, and methods of their use
#924Outer membrane vesicles and uses thereof
#925Infectious genomic DNA clone and serological profile of torque teno sus virus 1 and 2
#926Stimulation of neonatal immunity against EHV-1
#927Live attenuated infectious laryngotracheitis virus (ILTV) vaccines and preparation thereof
#928Reduced foaming vaccine compositions
#929Adjuvanted vaccines for in ovo avian vaccination
#930Bivalent swine influenza virus vaccine
#931Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#932Attenuated strains
#933Recombinant peptide vaccines against ticks, and nucleotide sequences coding for the recombinant peptides
#934Method of inducing tolerance to an allergen
#935Toothpaste for delivery of allergens to oral mucosa
#936Influenza virus mutants and uses therefor
#937Influenza virus mutants and uses therefor
#938spp. polypeptides and methods of use
#939LPS VACCINE
#940Dry formulations of vaccines that are room temperature stable
#941Live bacterial vectors for prophylaxis or treatment
#942PCV2B divergent vaccine composition and methods of use
#943Recombinant Marek's disease viruses and uses thereof
#944LYME DISEASE VACCINES
#945Porcine torque teno virus vaccines and diagnosis
#946Canine health product containing antibodies against canine parvovirus type 2
#947Methods of using presenting N-glycan or derivatives thereof
#948Vaccine Directed Against Porcine Pleuropneumonia and A Method to Obtain Such A Vaccine
#949Immunogenic middle east respiratory syndrome coronavirus (MERS-CoV) compositions and methods
#950Immunogenic compositions and methods for pigeon fever
#951Potomac horse fever isolates
#952Fowl adenovirus vaccine
#953Recombinant CDV compositions and uses thereof
#954Attenuated mannheimia haemolytica vaccines and methods of making and use
#955Fowl adenovirus vaccine
#956Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#957Vaccine
#958Efficient mucosal vaccination mediated by the neonatal Fc receptor
#959Swine dysentery vaccine
#960COMPOSITIONS AND METHODS FOR REDUCING INFECTION IN POULTRY
#961Rabies vaccine
#962Use of attenuated strains of parasites for the prevention or treatment of pathologies associates with an apicomplexan
#963Vaccines for diseases caused by viruses of the family of reoviridae
#964Attenuated Mannheimia haemolytica Vaccines and Methods of Making and Use
#965Method of making a mycoplasma vaccine
#966Mutated non-primate lentiviral Env proteins and their use as drugs
#967Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#968METHOD OF PROCESSING A VETERINARY TUMOR VACCINE AND A VETERINARY TUMOR VACCINE PROCESSING KIT
#969Attenuated swine influenza vaccines and methods of making and use thereof
#970Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
#971Porcine pseudorabies virus, vaccine composition and preparation method and use thereof
#972Recombinant HCMV and RHCMV vectors and uses thereof
#973Compositions and methods of enhancing immune responses
#974Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#975Adaptation of attenuated infectious bronchitis virus (IBV) to embryonic kidney cells and vaccine thereby produced
#976Vaccines against pathogenic and methods of using the same
#977Interactions of betanodaviruses in infection
#978Production of polypeptides relevant to human and animal health using
#979Vaccines and methods to treat lyme disease in dogs
#980Attenuated african swine fever virus strain induces protection against challenge with homologous virulent parental virus georgia 2007 isolate
#981Vaccine against streptococcal infections based on recombinant proteins
#982Vaccine for PCV2 and mycoplasma
#983Vaccine to prevent mycoplasmal infections in waterfowl
#984Porcine reproductive and respiratory syndrome virus compositions and uses thereof
#985Immunogenic compositions containing H7 flagella and methods of use thereof
#986Fungal immunogens and related materials and methods
#987Bluetongue virus vaccine and immunogenic compositions, methods of use and methods of producing same
#988Toxins in type A
#989Stabilised FMDV capsids
#990Methods for improving immunological response in vaccinated animals
#991H3 influenza a virus
#992Cancer vaccine for cats
#993Cancer vaccine for dogs
#994Fusion polypeptides and vaccines
#995Vaccine against bovine leukemia virus
#996Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#997Campylobacter vaccine
#998NOVEL PRRS VIRUS INDUCING TYPE I INTERFERON IN SUSCEPTIBLE CELLS
#999Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#1000Attenuation of infectious bronchitis virus variant GA-13
#1001Bovine virus vaccines that are liquid stable
#1002COMPOSITIONS, VECTORS, KITS, AND METHODS FOR IMMUNIZING AGAINST AVIAN INFECTIOUS BRONCHITIS VIRUS
#1003Vaccine delivery devices
#1004Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic Sendai virus
#1005Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof
#1006Compositions produced using enteric pathogens and methods of use
#1007Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
#1008Compositions and methods of enhancing immune responses to or limiting infection
#1009Vaccine for preventing porcine edema disease
#1010Immunologically active compositions
#1011Recombinant outer membrane proteins from and uses thereof
#1012Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
#1013Prevention and treatment of sub-clinical PCVD
#1014Vaccines for control of epidemic generated by markerless gene deletion
#1015Subunit immersion vaccines for fish
#1016Vaccine for intrauterine disease
#1017Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV)
#1018Effective method of treatment of porcine circovirus and infections
#1019ARTERIVIRUS
#1020Combination of protein forms for hornfly vaccination
#1021spp. polypeptides and methods of use
#1022Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)
#1023Vectors for transforming , transformed strains, and use thereof
#1024NOVEL MUCOSAL ADJUVANTS AND DELIVERY SYSTEMS
#1025Emulsion vaccine compositions comprising antigen and adjuvant in the aqueous phase
#1026Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#1027Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#1028Multivalent PCV2 immunogenic compositions and methods of producing such compositions
#1029Preparation of live vaccines
#1030Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
#1031Cross-reactive determinants and methods for their identification
#1032Cross-protecting vaccines
#1033COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF MALIGNANT GLIOMAS
#1034PCV/mycoplasma hyopneumoniae/PRRS combination vaccine
#1035vaccine
#1036Porcine epidemic diarrhea virus vaccine
#1037Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
#1038Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
#1039PCV/combination vaccine
#1040Immunogenic compositions including SIRS virus
#1041Modular antigen transportation molecules and uses therof
#1042Formulations for non-invasive delivery of active proteins to an animal or human
#1043Genetically engineered swine influenza virus and uses thereof
#1044Prophylaxis and treatment of PRDC
#1045Immunological compositions containing attenuated
#1046Compositions and methods for enterohemorrhagic (EHEC)vaccination
#1047Immunostimulatory plasmids
#1048JNK inhibitor molecules
#1049Peptide for reducing the phosphate requirement and excretion from farm animals
#1050Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#1051Cooperia vaccine
#1052Bacterial composition for the treatment of colibacillosis on farms, in particular poultry farms, and also drinking water containing such a bacterial composition
#1053Liquid stable virus vaccines
#1054Porcine parvovirus 5A, methods of use and vaccine
#1055USE OF THE SALMONELLA SPP TYPE III SECRETION PROTEINS AS A PROTECTIVE VACCINATION
#1056Salmonid alphavirus and uses thereof
#1057Cross-reactive T cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats
#1058Immunogenic composition of killed bacteria
#1059IgE peptide vaccine
#1060Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
#1061Vaccine formulations comprising saponin-containing adjuvants
#1062OX40L fusion protein for the immunotherapy of tumors of veterinary animals
#1063Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein C and uses thereof
#1064Use of a PCV2 immunogenic composition for lessening clinical symptoms in pigs
#1065PCV2 immunogenic compositions and methods of producing such compositions
#1066Arterivirus protein and expression mechanisms
#1067fHbp variant and its use for vaccination
#1068Vaccination by means of recombinant yeast by producing a protective humoral immune response against defined antigens
#1069Methods of vaccine administration
#1070Circovirus sequences associated with piglet weight loss disease (PWD)
#1071Probiotic for amelioration of coccidiosis vaccine reaction
#1072Circovirus sequences associated with piglet weight loss disease (PWD)
#1073Veterinary vaccine
#1074PCV2 immunogenic compositions and methods of producing such compositions
#1075Canine respiratory coronavirus for treatment and protection against bacterial infections
#1076Newcastle disease virus vectored herpesvirus vaccines
#1077Chicken Astrovirus Responsible for Runting Stunting Syndrome
#1078Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
#1079Oil-based adjuvants
#1080toxoid vaccine
#1081Fish vaccine
#1082Bacterial vaccine components and uses thereof
#1083Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
#1084Attenuated vaccines and methods of making and use thereof
#1085Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species
#1086Infectious bursal disease (IBDV) vaccine compositions
#1087Methods of inhibiting gonad maturation
#1088vaccine serovar type four
#1089LPS vaccine
#1090Method for immunizing an avian species
#1091Prevention of inflammatory disorders in domestic non-human mammals
#1092Canine babesiosis vaccine antigen
#1093Materials and methods for respiratory disease control in canines
#1094Sheep nematode vaccine
#1095Recombinant VapA and VapC peptides and uses thereof
#1096Treatment of pigs with PCV2 antigen
#1097Methods and compositions to protect aquatic invertebrates from disease
#1098Attenuated live bacteria with increased acid resistance and methods of use thereof
#1099PIV5 as oncolytic agent
#1100Synthetic capsid proteins and uses thereof
#1101Porcine circovirus type-2 (PCV2) subunit vaccine
#1102Immunogenic compositions comprising
#1103Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (PRRS)
#1104West Nile Virus vaccine
#1105Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
#1106Induction of mucosal tolerance to antigens
#1107Induction of mucosal tolerance to antigens
#1108Nucleic acids encoding interleukin-31 monoclonal antibody and uses thereof
#1109IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
#1110Infectious CDNA clone of european PRRS virus and uses thereof
#1111Reverse genetics Schmallenberg virus vaccine compositions, and methods of use thereof
#1112Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1113Vaccine
#1114Recombinant nonpathogenic MDV vector providing multivalent immunity
#1115Use of the PACAP as a molecular adjuvant for vaccines
#1116Modified gram-negative bacteria for use as vaccines
#1117Liquid stable bovine virus vaccines
#1118Bovine virus vaccines that are liquid stable
#1119Vaccination of companion animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
#1120Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
#1121European PRRSV strain
#1122DNA vaccine, method of inducing the immune response, method of immunisation, antibodies specifically recognising the H5 haemagglutinin of an influenza virus and use of the DNA vaccine
#1123Spray dried compositions and methods of use
#1124cDNA construct of Salmonidae alphavirus
#1125Newcastle disease virus vectored avian vaccines
#1126Live bacterial vaccines for prophylaxis or treatment of infection
#1127Modified live flavobacterium strains, stabilized vaccines comprising same, and methods of making and use thereof
#1128Live attenuated chimeric porcine circovirus vaccine
#1129Immunizing composition
#1130Prevention of recrudescense
#1131Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
#1132Immunostimulatory oligodeoxynucleotides
#1133Canine coronavirus vaccine
#1134Recombinant vaccine against PRRS in a viral vector
#1135Method of making a mycoplasma vaccine
#1136Potomac horse fever isolates
#1137Emulsion containing a non-live medicinal substance
#1138spp. polypeptides and methods of use
#1139spp. polypeptides and methods of use
#1140spp. polypeptides and methods of use
#1141Porcine reproductive and respiratory syndrome virus compositions and uses thereof
#1142Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
#1143Recombinant low virulence bovine herpesvirus-1 (BoHV-1) vaccine vectors
#1144Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof
#1145Method for producing vaccinal viral strain of a virus of the family
#1146Infectious bronchitis virus (IBV) spike protein as subunit vaccine
#1147Compositions and methods for vaccinating cattle
#1148Influenza virus mutants and uses therefor
#1149Recombinant mycobacterium avium subsp. paratuberculosis proteins induce immunity and protect against infection
#1150Peptide for protection of allergic respiratory disorders
#1151Yeast expressed classical swine fever virus glycoprotein E2 and use thereof
#1152Combined vaccines for prevention of porcine virus infections
#1153Adjuvant for the preparation of vaccine compositions intended for the prevention of coccidiosis
#1154Compositions for canine respiratory disease complex
#1155Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure
#1156North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#1157Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins
#1158Liquid stable virus vaccines
#1159Adjuvant compositions
#1160Immunization of avians by administration of non-replicating vectored vaccines
#1161Bivalent vaccine for marine fish and method for making the same
#1162Attenuated swine influenza vaccines and methods of making and use thereof
#1163Method of providing protective immunity against heterologous leptospira strains
#1164Non-pathogenic serotype 4 fowl adenovirus (fadv-4) and viral vector thereof
#1165Compositions and methods for treating and preventing porcine reproductive and respiratory syndrome
#1166Attenuated vaccines and methods of making and use thereof
#1167Reassortant BTV and AHSV vaccines
#1168Salmonid alphavirus protein E2
#1169Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
#1170Schmallenberg virus (SBV) vaccine, methods of production, and uses thereof
#1171Newcastle disease virus and the use thereof as a vaccine
#1172Vaccination of animals to elicit a protective immune response against tick infestations and tick-borne pathogen transmission
#1173Infectious genomic DNA clone and serological profile of Torque teno sus virus 1 and 2
#1174Effective vaccination against porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning
#1175Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
#1176Vaccine for protection against
#1177Reduction of concomitant infections in pigs by the use of PCV2 antigen
#1178Roadmap for controlling malaria
#1179Live attenuated catfish vaccine and method of making
#1180Vaccine against
#1181Vaccines for inclusion body hepatitis
#1182Nucleic acid and amino acid sequences, and vaccine for the control of ectoparasite infestations in fish
#1183Polypeptides and their use in treating and limiting respiratory syncytial virus infection
#1184Vaccines with live bacterial isolates for systemic administration
#1185Prevention and treatment of sub-clinical PCVD
#1186Outer membrane proteins of and methods thereof
#1187PCV/mycoplasma hyopneumoniae/PRRS combination vaccine
#1188PCV/combination vaccine
#1189vaccine
#1190Designer peptide-based PCV2 vaccine
#1191Vaccine against streptococcal infections based on recombinant proteins
#1192One dose vaccination against infections of pigs
#1193Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
#1194Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)
#1195Methods for detecting antibody that specifically bind a siderophore receptor polypeptide
#1196Immunoreactive antigens of and diagnostic immunoassay
#1197Recombinant poxviral vectors expressing both rabies and OX40 proteins, and vaccines made therefrom
#1198Rotavirus subunit vaccines and methods of making and use thereof
#1199Avirulent variants and pharmaceutical composition using the same
#1200Live attenuated parvovirus